CIM

Chimera Investment Corporation
CAPPED RATING

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of residential, commercial mortgage loans, and other real estate related securities. It has elected to be taxed as a REIT. In addition, the company invests in investment, non-investment grade, and non-rated classes. The company was incorporated in 2007 and is based in New York, New York.

Chimera Investment Corporation (CIM) is rated C- (1.9/5) on Deltasharpe Prism, scored against Real Estate sector peers. Its strongest pillar is Revisions (C); its weakest is Momentum (D-).

Quantitative Factor Evaluation • Updated

Overall Rating
1.9 / 5.0
C-
Value
C
Factor Score 2.3 / 5.0
Growth
C-
Factor Score 1.9 / 5.0
Profitability
C-
Factor Score 1.9 / 5.0
Momentum
D-
Factor Score 1.1 / 5.0
Revisions
C
Factor Score 2.4 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 3.4
EV / EBITDA N/A
Rev Growth YoY N/A
Gross Margin 61.2%
Price Return 3M -38.2%
Price Return 12M -33.8%
Catalyst Signal 0.00
Market Cap $585.2M
TTM Revenue $57.0M
Price / Sales 10.3
ROE -7.2%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-11 C (2.3) C- (1.9) C- (1.9) D- (1.1) C (2.4) C- (1.9)
2026-11-04 B (3.5) C- (1.9) C (2.5) D (1.3) C (2.4) C (2.3)
2026-10-28 B (3.4) D+ (1.8) C (2.5) D (1.3) C (2.4) C (2.3)
2026-10-21 B (3.4) D+ (1.8) C (2.5) D+ (1.7) C (2.4) C (2.4)
2026-10-14 B (3.3) C- (1.9) C (2.5) D+ (1.6) C (2.3) C (2.3)
Page 1 of 4